Free Newsletter
Big pharma to close 26 more plants
Well, big pharma doesn't appear to be the safe haven for investors or employees these days. The Industrial Info Resources' Pharmaceutical Tracker has revealed that there are at least 26 plants poised for shutdown. This is in addition to those J&J, Pfizer and Schering-Plough and other layoffs we keep hearing about, and employees in pharmaceutical advertising and marketing might take the biggest hit.
Why the slump? The combination of a down economy coupled with patent expirations, negative press about popular medications, fewer prescriptions being filled and some FDA difficulties might be to blame. Continued rumors about layoffs and plant closures are unlikely to help much, either.
- read the report
- get the story in BusinessWeek
- see more at Market Watch
- here's World of DTC Marketing's take
Relate dArticles:
Fortune snubs Big Pharma in employers list
Top 8 layoffs of 2007
Pharma layoffs set new record
Comments
Post new comment
Paid Research Reports
- The Top 10 Biosimilar Players: Positioning, performance and SWOT analyses
- New Approaches to Pharma R&D: Evolving strategies to rejuvenate R&D efficiency
- Stakeholder Opinions: Vaccine antigen delivery technologies - Molecular systems to open new markets
- The Top 10 Contract Research Organizations
- Stakeholder Opinions: Vaccine administration technologies - Beyond needles
- Future Pharmaceutical Industry Trends: Long-term opportunities tempered by short-term challenges





Click here to get the FiercePharma email newsletter for FREE!
Be the first to comment